Clinical Report: Evolution of Scleral Lenses from 2010 to 2025
Overview
The 2025 Global Specialty Lens Symposium highlighted significant advancements in scleral lens technology and applications over the past 15 years. These developments have expanded indications and improved management of complex ocular conditions, enhancing patient outcomes.
Background
Scleral lenses have evolved considerably since 2010, transforming vision care for patients with irregular astigmatism, keratoconus, ocular surface diseases, and post-surgical complications. Modern lenses vault over the cornea and rest on the conjunctiva, supported by advanced diagnostic and fitting technologies. Increased practitioner confidence and patient awareness have broadened the clinical use of scleral lenses, including in severe dry eye disease and post-transplant management.
Data Highlights
The course emphasized the use of advanced technologies such as topography, tomography, and impression-based lens designs to optimize scleral lens fitting. It also addressed complications like midday fogging and strategies to mitigate them using improved lens materials, coatings, and solutions. Case-based discussions illustrated successful fittings across a spectrum of corneal conditions, from normal to severely irregular.
Key Findings
- Scleral lenses have expanded indications, including irregular astigmatism, keratoconus, ocular surface diseases, and post-surgical conditions.
- Modern scleral lenses vault over the cornea and land on the conjunctiva, improving comfort and fit.
- Advanced diagnostic tools such as topography and tomography enhance lens fitting precision.
- Scleral lenses effectively manage severe dry eye disease, including Sjögren’s syndrome, by improving tear film stability.
- Complications like midday fogging can be mitigated through selection of lens materials, coatings, and solutions.
- Successful management of post-surgical complications such as corneal edema and transplant rejection is achievable with scleral lenses.
Clinical Implications
Clinicians should leverage advanced diagnostic technologies and a variety of lens materials and surface treatments to individualize scleral lens care. Proactive identification and management of contributing conditions like meibomian gland dysfunction or Demodex infestations are essential to optimize lens wear success and minimize complications such as inflammation and fogging.
Conclusion
The evolution of scleral lenses over the past 15 years has significantly enhanced their clinical utility and patient outcomes. Ongoing advancements in technology and understanding of ocular surface conditions continue to refine fitting strategies and expand therapeutic applications.
References
- 2025 Global Specialty Lens Symposium -- GSLS Course Traces the Evolution of Scleral Lenses from 2010 to the Present
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.